Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia.
Vergori A, Lorenzini P, Cozzi-Lepri A, Donno DR, Gualano G, Nicastri E, Iacomi F, Marchioni L, Campioni P, Schininà V, Cicalini S, Agrati C, Capobianchi MR, Girardi E, Ippolito G, Vaia F, Petrosillo N, Antinori A, Taglietti F; ReCOVeRI Study Group. Vergori A, et al. Sci Rep. 2021 May 31;11(1):11334. doi: 10.1038/s41598-021-90713-6. Sci Rep. 2021. PMID: 34059708 Free PMC article.
Prophylactic low molecular weight heparin (pLMWH) is currently recommended in COVID-19 to reduce the risk of coagulopathy. The aim of this study was to evaluate whether the antinflammatory effects of pLMWH could translate in lower rate of clinical progression …
Prophylactic low molecular weight heparin (pLMWH) is currently recommended in COVID-19 to reduce the risk of coagulopathy. The …
Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020.
Bordi L, Nicastri E, Scorzolini L, Di Caro A, Capobianchi MR, Castilletti C, Lalle E; on behalf of INMI COVID-19 study group and Collaborating Centers2. Bordi L, et al. Euro Surveill. 2020 Feb;25(8):2000170. doi: 10.2807/1560-7917.ES.2020.25.8.2000170. Euro Surveill. 2020. PMID: 32127123 Free PMC article.
A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countri …
A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named C …